2017
DOI: 10.1016/j.remn.2016.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Utilidad de los parámetros analíticos en el manejo de los pacientes pediátricos con sospecha de pielonefritis aguda. ¿Es fiable la procalcitonina?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 27 publications
0
4
0
Order By: Relevance
“…Numerous studies have evaluated the usefulness of inflammatory markers for predicting APN, and demonstrated that commonly used laboratory parameters such as WBC, CRP and ESR have low sensitivity and specificity for accurately predicting acute renal parenchymal involvement. At present, these tests are not recommended for routine use to differentiate APN from lower UTI in children [11, 12, 14]. A previous meta-analysis showed that PCT was unable to predict APN in children [12].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Numerous studies have evaluated the usefulness of inflammatory markers for predicting APN, and demonstrated that commonly used laboratory parameters such as WBC, CRP and ESR have low sensitivity and specificity for accurately predicting acute renal parenchymal involvement. At present, these tests are not recommended for routine use to differentiate APN from lower UTI in children [11, 12, 14]. A previous meta-analysis showed that PCT was unable to predict APN in children [12].…”
Section: Discussionmentioning
confidence: 99%
“…Similar to reports of Bańuelos-Andrio et al . and Pathirana et al ., we evaluated infants with febrile and non-febrile UTI [11, 42]. Four children with non-febrile UTI presented a positive DMSA scan.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, it is an invasive test, which radiates the patient and is not available in all centers. On the other hand, there are biomarkers of parenchymal involvement like C-reactive protein (CRP) or procalcitonin (PCT), but none of them are sensitive and specific enough to replace DMSA scan [10][11][12][13]. For this reason, new molecules that can help with an early detection of those patients at risk of kidney damage continue to be investigated [14,15].…”
Section: Introductionmentioning
confidence: 99%